Catalyst Pharmaceuticals Announces Change to a Virtual Meeting Format for the 2020 Annual Meeting of StockholdersGlobeNewsWire • 08/03/20
Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 11th, 2020GlobeNewsWire • 08/03/20
Catalyst Pharmaceuticals Comments on Magistrate Judge's Report and Recommendation in its Lawsuit against the FDAGlobeNewsWire • 07/31/20
Earnings Preview: Catalyst Pharmaceutical (CPRX) Q2 Earnings Expected to DeclineZacks Investment Research • 07/29/20
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Catalyst Pharmaceuticals, Inc. - CPRXNewsfile Corp • 07/16/20
Catalyst Pharmaceuticals Appoints Jeffrey Del Carmen as Chief Commercial OfficerGlobeNewsWire • 06/23/20
Catalyst (CPRX) Down 0.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/10/20
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20
Catalyst (CPRX) Up 52.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 04/15/20
Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business ActivitiesGlobeNewsWire • 04/08/20
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/17/20
Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: What to Know Ahead of Q4 ReleaseZacks Investment Research • 03/09/20
Do Options Traders Know Something About Catalyst (CPRX) Stock We Don't?Zacks Investment Research • 02/25/20
Catalyst Pharmaceuticals Appoints David Ailinger as Vice President, Business DevelopmentGlobeNewsWire • 02/04/20
Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development ProgramsGlobeNewsWire • 01/06/20